Alkemi Capital to invest in Datar Cancer Genetics.

Alkemi Capital, a growth capital investment firm based in New Delhi, India, agreed to invest in Datar Cancer Genetics, a molecular oncology facility. Financial terms were not disclosed. The fundraise will happen by way of subscription to compulsorily convertible preference shares and nominal equity shares in the Company.